Dibikor Tablets 250 mg, # 60

Dibikor tab.

250mg No. 60

Name ENG

DIBICOR

Clinical and pharmacological group

A drug that improves metabolism and energy supply of tissues

ATX code

Other drugs for the treatment of heart disease

Dosage

250mg

Structure

Active substance: taurine 250 mg

excipients: MCC - 23 mg

potato starch - 18 mg

gelatin - 6 mg

colloidal silicon dioxide (aerosil) - 0.3 mg

calcium stearate - 2.7 mg

INN / Active ingredient

Taurine

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Specifications

Scope of the drug

Heart, vessels, blood

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

60

Scope of application

Cardiology

Minimum age from

18 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Peak Pharma

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Metabolic agent

Anatomical and therapeutic characteristics

C01EB Other drugs for the treatment of heart diseases

Dosage form

Pills

Packaging

Box

Dosage (volume) of the substance in the preparation

1 tab .: taurine 250 mg

The target audience

Adult

Expiration date in days

1095

Package weight, g

35

Category

:

Improving blood circulation

,

Angioprotectors and microcirculation correctors

,

Lipid-lowering drugs

,

Hematopoietic stimulants

Mode of application

:

Dibikor is taken orally, 20 minutes before meals.

With heart failure - 250-500 mg 2 times a day, the course of treatment is 30 days.

The dose can be increased to 2-3 g / day or reduced to 125 mg per dose. In type 2 diabetes mellitus, 500 mg 2 times a day as monotherapy or in combination with tableted antihyperglycemic agents. In type 1 diabetes, 500 mg. mg 2 times a day in combination with insulin therapy for 3-6 months.